SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: Gene therapy seems to be a promising treatment for Dravet syndrome and clinical trials with antisense oligonucleotides (ASOs)8 able to increase Nav1.1 expression are already ongoing.